Metastatic Breast Cancer

Despite differences in tumors, the addition of CDK 4/6 inhibitors to endocrine therapy showed a benefit in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer compared with endocrine therapy alone.

The three-drug combination of Perjeta and Herceptin with Gemzar shows improved progression-free survival in patients with metastatic breast cancer to advance to a phase 3 trial.

When making treatment decisions in breast cancer, patient concerns about how each treatment will affect their daily life — and their disease stage — have an important role to play, according to Dr. Sara Hurvitz.

The safety profile and effectiveness of each therapeutic option are both important considerations to keep in mind when clinicians and patients weigh their breast cancer treatment options, according to one expert.

Why this breast cancer survivor thinks more oncologists should be listening carefully to patients on social media.

The FDA has approved subcutaneous use of Herceptin and Herceptin Hylecta in combination with chemotherapy for the treatment of select patients with HER2-positive early breast cancer.

Meeting others, learning tips, hearing from docs: breast cancer patients have it all when they get together.

Three ways this metastatic breast cancer patient has made research participation a part of her life.

Real resolutions to make 2019 feel like a year of finally putting away unachievable goals from the past.

Here are the top 5 CURE stories for December 2018.

Cancer has led me to men and women who grabbed onto life but died anyway.

Four years' worth of high-stakes scans have made me an expert in four excellent ways to ease intense anxiety.

Emotions are not an either/or proposition when it comes to metastatic cancer.

Additional factors now help determine a breast cancer’s stage, making prognoses more accurate.

Metastatic breast cancer advocate goes to Washington DC to tell her own story and push for more research to be directed toward metastatic disease

For some breast cancer survivors, 3D nipple tattooing is the right choice. Others may turn to body art or choose to do nothing at all.

With this FDA action, Talzenna (talazoparib) is the second PARP inhibitor to be approved in the breast cancer space.

The words celebrities use carry an enormous amount of weight.

A few thoughts and simple methods for finding a way to get back to the center of a life that includes all the emotions

Positive results, clinical utility, curtailed curiosity – has the desire for good news slowed the path to a cure?

Talazoparib reduced the risk for disease progression or death by 46 percent and improved quality of life compared with chemotherapy in a subgroup of women with breast cancer, according to the phase 3 EMBRACA trial results.

Lost homes, delayed treatments, death. Metastatic breast cancer patients have a shot at changing the access paradigm.

NCCN guidelines recommend annual mammograms to detect disease recurrence, but according to the study’s findings, women — even those who had adequate health insurance — were less likely to have their once-a-year mammogram as they became long-term survivors.

The findings of a new study show that women with young children have concerns that affect emotional well-being.